Concerns that the proposed acquisition of Sirtex Medical by a Chinese private equity firm would leave the company with insufficient funds to cover a settlement or judgement in a class action were eased Wednesday, after a barrister said the takeover would leave the company with just under $1 billion in assets.
Australian drug company Homart Pharmaceuticals has lost an appeal of a ruling that found the packaging of its bio-placenta skin care oil was intentionally and deceptively similar to a rival’s get-up, in breach of the consumer law.
The Full Federal Court has found products that market themselves as “natural” need not be made wholly of natural ingredients, handing a win to Aldi on appeal in its legal battle with the maker of the popular MoroccanOil line of hair products.